Related Experiment Video
Updated: Sep 4, 2025

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
A new circular RNA-encoded protein BIRC6-236aa inhibits transmissible gastroenteritis virus (TGEV)-induced
Xiaomin Zhao1, Jianxiong Guo1, Xinyue Wang1
1College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, P.R. China.
Abstract:
Transmissible gastroenteritis virus (TGEV), a member of the coronavirus family, is the pathogen responsible for transmissible gastroenteritis, which results in mitochondrial dysfunction in host cells. Previously, we identified 123 differentially expressed circular RNAs (cRNA)from the TGEV-infected porcine intestinal epithelial cell line jejunum 2 (IPEC-J2). Previous bioinformatics analysis suggested that, of these, circBIRC6 had the potential to regulate mitochondrial function. Furthermore, mitochondrial permeability transition, a key step in the process of mitochondrial dysfunction, is known to be caused by abnormal opening of mitochondrial permeability transition pores (mPTPs) regulated by the voltage-dependent anion-selective channel protein 1 (VDAC)-Cyclophilin D (CypD) complex. Therefore, in the present study, we investigated the effects of circBIRC6-2 on mitochondrial dysfunction and opening of mPTPs. We found that TGEV infection reduced circBIRC6-2 levels, which in turn reduced mitochondrial calcium (Ca2+) levels, the decrease of mitochondrial membrane potential, and opening of mPTPs. In addition, we also identified ORFs and internal ribosomal entrance sites within the circBIRC6-2 RNA. We demonstrate circBIRC6-2 encodes a novel protein, BIRC6-236aa, which we show inhibits TGEV-induced opening of mPTPs during TGEV infection. Mechanistically, we identified an interaction between BIRC6-236aa and VDAC1, suggesting that BIRC6-236aa destabilizes the VDAC1-CypD complex. Taken together, the results suggest that the novel protein BIRC6-236aa encoded by cRNA circBIRC6-2 inhibits mPTP opening and subsequent mitochondrial dysfunction by interacting with VDAC1.
Insights
Transmissible gastroenteritis virus (TGEV) infection disrupts mitochondrial function. A novel protein, BIRC6-236aa, encoded by circBIRC6-2, prevents this disruption by inhibiting mitochondrial permeability transition pores.
Area of Science:
- Virology
- Cell Biology
- Molecular Biology
Background:
- Transmissible gastroenteritis virus (TGEV) causes disease by inducing mitochondrial dysfunction.
- Circular RNAs (circRNAs) are implicated in cellular processes, with some potentially regulating mitochondrial function.
- Mitochondrial permeability transition pores (mPTPs), regulated by VDAC1-CypD complex, are key in mitochondrial dysfunction.
Purpose of the Study:
- To investigate the role of circBIRC6-2 in TGEV-induced mitochondrial dysfunction.
- To identify the protein product of circBIRC6-2 and elucidate its mechanism of action.
Main Methods:
- Analysis of circRNA expression in TGEV-infected porcine intestinal epithelial cells (IPEC-J2).
- Assessment of mitochondrial function markers (calcium levels, membrane potential, mPTP opening).
- Identification of open reading frames (ORFs) in circBIRC6-2 and protein interaction studies.
Main Results:
- TGEV infection decreased circBIRC6-2 levels, leading to reduced mitochondrial calcium, membrane potential, and increased mPTP opening.
- circBIRC6-2 encodes a novel protein, BIRC6-236aa.
- BIRC6-236aa inhibits TGEV-induced mPTP opening.
- BIRC6-236aa interacts with VDAC1, destabilizing the VDAC1-CypD complex.
Conclusions:
- The novel protein BIRC6-236aa, derived from circBIRC6-2, protects against TGEV-induced mitochondrial dysfunction.
- BIRC6-236aa exerts its protective effect by inhibiting mPTP opening via interaction with VDAC1.
- circBIRC6-2 represents a potential therapeutic target for TGEV infections.
Related Concept Videos
Leaky Scanning
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Viruses with RNA Genomes
Experimental RNAi
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Subviral Agents

